Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $1.9252W HIGH $68.85
Volume
10.22 K
Value Traded
43.21 K
Short % Float
3.27%
Days to Cover
2.3
-2.78%Week
-19.23%1 Month
-48.53%3 Month
+73.55%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
8.44 M
EPS (TTM)
-6.62
P/E Ratio
-
Ent. Value
-32.99 K
Total Shares
2.01 M
Float Shares
1.80 M
Insiders
14.45%
Institutions
10.95%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
ASTC Catalyst Timeline
Dated clinical, regulatory and corporate events for Astrotech Corporation (DE)
Past FDA Catalysts and PDUFA Decisions
How ASTC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Astrotech Corporation (DE) is a diagnostics company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every ASTC program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Winn Charles ArchDirector | Grant/Award | 6,006 9,895 held | $0.00 | 04/14/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in ASTC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in ASTC for Q2 2026. | ||||
Ownership Trends
ASTC Short Interest
Shares sold short, counted twice a month.
3.27%
Short % of Float
of tradable shares sold short
58.9K
Shares Sold Short
-4.2% vs prior count
2.3 Moderate
Days to Cover
trading days of normal volume to buy every short share back
25.8K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How ASTC ranks across every disease it competes in
Competitive Position is a premium feature
See how ASTC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialASTC News
-ASTC
Nov 13, 2026▼ -1.4%today
ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2027 FINANCIAL RESULTS
Astrotech Corporation reported its first quarter fiscal 2027 results ending September 30, 2026. Total operating expenses fell 15.7% to $3.1 million compared to the prior year. The company held $11.6 million in working capital to support ongoing operations. Additionally, Astrotech submitted a NASA proposal for its lunar power system initiative.
Read more →-ASTC
Sep 25, 2026ASTROTECH REPORTS FISCAL YEAR 2026 FINANCIAL RESULTS
Astrotech reported fiscal year 2026 results with $14 million in operating expenses, a 6% decline. The company deployed its TRACER 1000 in 37 locations across 16 countries. It also launched the Labrador ruggedized Handheld Gas Chromatograph. Astrotech holds $11.3 million in cash and approved lunar resource initiatives.
Read more →-ASTC
Feb 11, 2022ASTROTECH REPORTS SECOND QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS SECOND QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS Austin, Texas - February 11, 2022 - Astrotech Corporation (Nasdaq: ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 202
Read more →-ASTC
Jan 6, 2022▼ -7.3%on this news
ASTROTECH ANNOUNCES DATE FOR FISCAL YEAR 2021 ANNUAL MEETING AND DEADLINES FOR STOCKHOLDER PROPOSALS Austin, Texas
ASTROTECH ANNOUNCES DATE FOR FISCAL YEAR 2021 ANNUAL MEETING AND DEADLINES FOR STOCKHOLDER PROPOSALS Austin, Texas - January 6, 2022 - Astrotech Corporation (Nasdaq: ASTC) (the "Company") announced its plans to hold its fiscal year 2021 annual meeting of stockholders (the "2021
Read more →-ASTC
Nov 17, 2021ASTROTECH BEGINS SEARCH FOR STRATEGIC ACQUISITIONS Austin, Texas
ASTROTECH BEGINS SEARCH FOR STRATEGIC ACQUISITIONS Austin, Texas - November 17, 2021 - Astrotech Corporation (Nasdaq: ASTC) now intends to actively pursue strategic and accretive acquisition opportunities. Tom Wilkson, as Lead Independent Director, will focus on identifying stra
Read more →-ASTC
Nov 12, 2021ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS Austin, Texas - November 12, 2021 - Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the first quarter of fiscal year 2022, which ended September 30, 2021. The first quarter of fiscal
Read more →-ASTC
Sep 20, 2021▼ -7.3%on this news
ASTROTECH REPORTS FISCAL YEAR 2021 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS FISCAL YEAR 2021 FINANCIAL RESULTS Austin, Texas - September 20, 2021 - Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the fiscal year ended June 30, 2021. Fiscal year 2021 represented a turning point for Astrotech Corporation. We succ
Read more →-ASTC
May 13, 2021ASTROTECH REPORTS THIRD QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS THIRD QUARTER OF FISCAL YEAR 2021 Austin, Texas - May 13, 2021 - Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the third quarter of fiscal year 2021, which ended March 31, 2021. During and subsequent to quarter end, we continued to st
Read more →-ASTC
Apr 12, 2021This announcement is neither an offer to sell, nor a solicitation of an offer to buy, any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, soli
ASTROTECH ANNOUNCES $10 MILLION BOUGHT DEAL OFFERING OF COMMON STOCK Austin, Texas - April 7, 2021 Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purch
Read more →-ASTC
Apr 6, 202114.4Authority to Enter Agreement.
Certain confidential information contained in this document, marked by brackets and asterisks ([***]), has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed. INVESTIGATOR-I
Read more →-ASTC
Mar 30, 2021ASTROTECH ENGAGES SANMINA TO SCALE MANUFACTURING Austin, Texas
ASTROTECH ENGAGES SANMINA TO SCALE MANUFACTURING Austin, Texas - March 30, 2021 Astrotech Corporation (NASDAQ: ASTC) announced today that its Astrotech Technologies, Inc. subsidiary has entered into an agreement with Sanmina Corporation to manufacture its mass spectrometry prod
Read more →-ASTC
Feb 16, 2021ASTROTECH REPORTS SECOND QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS SECOND QUARTER OF FISCAL YEAR 2021 Austin, Texas - February 16, 2021 - Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the second quarter of fiscal year 2021, which ended December 31, 2020. Since the beginning of the quarter, we success
Read more →-ASTC
Feb 11, 2021Astrotech Announces $9.25 Million Registered Direct Offering Priced At-the-Market Austin, Texas
Astrotech Announces $9.25 Million Registered Direct Offering Priced At-the-Market Austin, Texas - February 11, 2021 - Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into definitive agreements with several institutional investors for the purchase and sa
Read more →-ASTC
Nov 12, 2020ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2021 Austin, Texas - November 12, 2020 - Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the first quarter of fiscal year 2021, which ended September 30, 2020. In October, we completed two strategic capital
Read more →-ASTC
Oct 29, 2020Astrotech Announces $6.2 Million Registered Direct Offering Priced At-the-Market Austin, Texas
Astrotech Announces $6.2 Million Registered Direct Offering Priced At-the-Market Austin, Texas - October 29, 2020 - Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into definitive agreements with several institutional investors for the purchase and sale
Read more →-ASTC
Oct 21, 2020ASTROTECH ANNOUNCES PRICING OF $18.0 MILLION UPSIZED PUBLIC OFFERING Austin, Texas
ASTROTECH ANNOUNCES PRICING OF $18.0 MILLION UPSIZED PUBLIC OFFERING Austin, Texas - October 21, 2020 Astrotech Corporation (Nasdaq: ASTC), today announced the pricing of a public offering of an aggregate of 7,826,086 shares of common stock, at a purchase price of $2.30 per sha
Read more →-ASTC
Oct 20, 2020IN WITNESS WHEREOF, the PARTIES, by their authorized representatives, have evidenced their consent to the terms provided herein by signing below. THE CLEVELAND CLINIC FOUNDATION BREATHTECH CORPORATION /s/ Steven C. Glass
Joint Development and Option Agreement This Joint Development and Option Agreement ("JDA"), effective and binding as of the last date of execution herein ("EFFECTIVE DATE"), is by and between The Cleveland Clinic Foundation (hereinafter referred to along with its AFFILIATEs as "
Read more →-ASTC
Sep 9, 2020ST DETECT'S TRACER 1000 ACHIEVES MILESTONE IN TSA AIR CARGO SCREENING QUALIFICATION TEST Austin, Texas
1ST DETECT'S TRACER 1000 ACHIEVES MILESTONE IN TSA AIR CARGO SCREENING QUALIFICATION TEST Austin, Texas - September 9, 2020 Astrotech Corporation's (NASDAQ: ASTC) 1st Detect subsidiary announced today that the TRACER 1000 passed the U.S. Transportation Security Administration's
Read more →-ASTC
Sep 8, 2020ASTROTECH REPORTS FISCAL YEAR 2020 FINANCIAL RESULTS - AgLAB Introduces the AgLAB-1000-D2 - Austin, Texas
ASTROTECH REPORTS FISCAL YEAR 2020 FINANCIAL RESULTS - AgLAB Introduces the AgLAB-1000-D2 - Austin, Texas - September 8, 2020 - Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the fiscal year ended June 30, 2020. Fiscal year 2020 has been a pivotal year
Read more →-ASTC
May 13, 2020ASTROTECH REPORTS THIRD QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS Austin, Texas
ASTROTECH REPORTS THIRD QUARTER OF FISCAL YEAR 2020 Austin, Texas - May 13, 2020 - Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the third quarter of fiscal year 2020, which ended March 31, 2020. This quarter was pivotal for the Company, as we continue
Read more →About Astrotech Corporation (DE)
Headquarters2105 DONLEY DR. SUITE 100, AUSTIN, TX, 78758
BIOPHARMAWATCH ELITE
Trade the next ASTC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime